Currently out of the existing stock ratings of Alexander Nowak, 129 are a BUY (86.58%), 4 are a SELL (2.68%), 16 are a HOLD (10.74%).

Alexander Nowak

Work Performance Price Targets & Ratings Chart

Analyst Alexander Nowak, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 50.67% that have a potential upside of 44.26% achieved within 222 days.

Alexander Nowak’s has documented 298 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Communication Services, Financial Services sectors.

Most recent stock forecast was given on BVS, Bioventus at 06-Mar-2026.

Wall Street Analyst Alexander Nowak

Analyst best performing recommendations are on DRIO (DARIOHEALTH CORP).
The best stock recommendation documented was for DRIO (DARIOHEALTH CORP) at 3/18/2020. The price target of $140 was fulfilled within 8 days with a profit of $64 (84.21%) receiving and performance score of 105.26.

Average potential price target upside

of $125.29 (76.9%) on DRIO (DARIOHEALTH CORP).
of $21.91 (48.92%) on TNDM (TANDEM DIABETES CARE).
of $20.48 (11.18%) on IDXX (IDEXX LABORATORIES).

CDNA Caredx CELC Celcuity LLC EXAS EXACT Sciences INFU InfuSystems Holdings NEO NeoGenomics NTRA Natera QDEL Quidel SDC SmileDirectClub TECH Bio-Techne Corp TNDM Tandem Diabetes Care DRIO DarioHealth Corp HTGM HTG Molecular Diagnostics SIEN Sientra DMAC DiaMedica Therapeutics BVS Bioventus ALIM Alimera Sciences CVRX CVRx GH Guardant Health IDXX IDEXX Laboratories NEON SE Sea Ltd SI Silvergate Capital

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mark Massaro (BTIG)